Abstract:Genomic integration of heterologous genes is the preferred approach in industrial fermentation-related strains due to the drawbacks associated with plasmid-mediated microbial fermentation, including additional growth burden, genetic instability, and antibiotic contamination. Synthetic biology and genome editing advancements have made gene integration convenient. Integrated expression is extensively used in the field of biomanufacturing and is anticipated to become the prevailing method for expressing recombinant proteins. Therefore, it is pivotal to strengthen the expression of exogenous genes at the genome level. Here, we systematically optimized the integrated expression system of Escherichia coli from 3 aspects. First, the integration site slmA with the highest expression activity was screened out of 18 sites in the ORI region of the E. coli BL21 (DE3) genome. Second, we characterized 16 endogenous promoters in E. coli and combined them with the T7 promoter. A constitutive promoter, Plpp-T7, exhibited significantly higher expression strength than the T7 promoter, achieving a 3.3-fold increase in expression levels. Finally, to further enhance the T7 expression system, we proceeded with overexpression of T7 RNA polymerase at the chassis cell level. The resulting constitutive efficient integrated expression system (CEIES_Ecoli) showed a 2-fold increase in GFP expression compared to the pET3b recombinant plasmid. Therefore, CEIES_Ecoli was applied to the integrated expression of nitrilase and hyaluronidase, achieving stable and efficient enzyme expression, with enzyme activities of 22.87 and 12,195 U·mL-1, respectively, comparable to plasmid levels. Overall, CEIES_Ecoli provides a stable and efficient method of gene expression without the need for antibiotics or inducers, making it a robust tool for synthetic biology, enzyme engineering, and related applications.

Developing the E. Coli Platform for Efficient Production of UMP-derived Chemicals

Combinatorial engineering of hybrid mevalonate pathways in Escherichia coli for protoilludene production

Engineering Escherichia Coli for High-Yielding 2,5-Dimethylpyrazine Synthesis from L-Threonine by Reconstructing Metabolic Pathways and Enhancing Cofactors Regeneration

Metabolic engineering of Escherichia coli for de novo production of 5-hydroxyvalerate via L-lysine α-oxidase pathway

Submerged fermentation of Streptomyces uncialis providing a biotechnology platform for uncialamycin biosynthesis, engineering, and production

EFFICIENT PRODUCTION OF URIDINE 5′-DIPHOSPHO-N-ACETYLGLUCOSAMINE BY THE COMBINATION OF THREE RECOMBINANT ENZYMES AND YEAST CELLS

Improving the level of the cytidine biosynthesis in E. coli through atmospheric room temperature plasma mutagenesis and metabolic engineering

Systematic Engineering of Escherichia coli for Efficient Production of Pseudouridine from Glucose and Uracil

Metabolic Engineering of Escherichia coli for Production of 2,5-Dimethylpyrazine

Metabolic Engineering of Escherichia coli for Efficient Production of Pseudouridine

Development of a Plasmid-Free Biosynthetic Pathway for Enhanced Muconic Acid Production in Pseudomonas Chlororaphis HT66

Improved synthesis of 2′-deoxyadenosine and 5-methyluridine by Escherichia coli using an auto-induction system

Multistep construction of metabolically engineered Escherichia coli for enhanced cytidine biosynthesis

Modularized Reconstruction of Pyrimidine Pathway in Escherichia Coli for Enhanced Pyrimidine Nucleosides Biosynthesis

Enhanced uridine 5′-monophosphate production by whole cell of Saccharomyces cerevisiae through rational redistribution of metabolic flux

Metabolic engineering of Escherichia coli for the efficient production of 5-hydroxyvaleric acid

Multiple Metabolic Engineering Strategies to Improve Shikimate Titer in Escherichia coli

[Metabolic engineering of Escherichia coli for thymidine production]

Metabolic Engineering of Escherichia Coli for the Production of L-Homoserine

Multilevel Systematic Optimization To Achieve Efficient Integrated Expression of Escherichia coli

Systems metabolic engineering of Escherichia coli for production of the antitumor drugs violacein and deoxyviolacein